A NEW WAY OF FARMING GETS A BOOST FROM PETROCHEMICALS

| March 3, 2019

article image
With the global population rising and a decline in arable land for crop production, people are looking for solutions to feed a growing world. Hydroponic farming, a technique for growing plants without any soil and with minimal water, is one high-tech solution that’s revolutionizing access to nutrition and offering hope for the future. Hydroponic farming is made possible by the use of advanced, engineered plastics enabled by petrochemicals. In a contained hydroponic system, limited amounts of nutrient-rich water come in direct contact with exposed plant roots. Temperature controlled hydroponic farms have a year-round growing season and allow fresh produce to bloom in crowded urban areas and food deserts, minimizing the distance from plant to plate.

Spotlight

Avanir Pharmaceuticals

A company with a cause. People with a passion. Together, they make a world of difference. Every day at Avanir Pharmaceuticals, Inc. we focus on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. That focus, along with the deep-seated passion of our people, is fueling the development of innovative medical solutions. It’s a personal thing for us. If you’ve ever known someone suffering from a CNS disorder, you probably understand. Millions of people struggle daily with these complex and difficult conditions and yet, there are no perfect solutions. Enter Avanir where our vision is to become the leading pharmaceutical company in the CNS space because that, in turn, will enable us to follow our passion of helping CNS patients every day. And we think that’s a great thing to do.

OTHER ARTICLES
CHEMICAL MANAGEMENT

Southeast polyolefins demand growth could be negative again in 2021

Article | July 13, 2021

BEFORE the pandemic, GDP growth rates in the developing world were always higher than in developed economies.And because developing economies had much lower levels of petrochemicals consumption than their rich counterparts, it meant that the multiples over GDP were higher than in the rich word, where consumption was pretty much saturated. For instance, polyethylene (PE) demand in a developed country such as Germany might have grown at 0.3% times GDP whereas in Indonesia the growth could have been one or more times higher than the rate of growth in GDP.But as The Economist wrote in this 11 July article: “In 2021 the poorest countries, which are desperately short of vaccines, are forecast to grow more slowly than rich countries for only the third time in 25 years.” Might the multiples over GDP growth also be adversely affected in the developing world, trending lower than the historic norms? They will almost certainly remain higher than the rich countries. But here is the thing: as millions more people are pushed back into extreme poverty by the pandemic or are denied the opportunity to achieve middle-income status, I believe that developing-world multiples may well decline.Escaping extreme poverty means being able to, say, afford a whole bottle of shampoo for the first time rather than a single-serve sachet, thereby raising per capita polymers consumption.

Read More
CHEMICAL MANAGEMENT

Pandemic’s third wave seems unlikely to damage global petrochemicals demand

Article | July 22, 2021

Petrochemical stocks plunged worldwide on 19 July ahead of the Q2 earnings season. The declines were consistent with those in economically sensitive sectors such as steel, copper, automotive and housing,” wrote my ICIS colleague, Joseph Chang, in this Insight article.

Read More
CHEMICAL TECHNOLOGY

Reimagining the Workforce with Anglo American

Article | June 21, 2021

“At Anglo-American, we’re really focused on finding the best ways to attract the most talented people in the industry and effectively equipping our existing workforce based on what they need today and what the future will mean for their careers. We’re also committed to providing learning opportunities that lead to growth and development in the communities in which we operate. Our people are a strategic advantage. We want to ensure that continues to be the case as the mining industry evolves and faces more disruption.

Read More
CHEMICAL MANAGEMENT

Energy portfolio restructuring: Charting the future

Article | June 17, 2021

Consumer needs and preferences in the energy industry are evolving. Environmental, social and governance (ESG) concerns are becoming more acute—inspiring action and shifting value towards low-carbon solutions. These trends accelerated in 2020 and for the first time, market capitalization of leading low-carbon solutions companies began to overtake those of oil and gas (O&G) majors. This is despite the majors laying out energy transition strategies, setting low carbon energy targets and generating higher revenues by an order of magnitude.1 In response to this radically changing landscape, energy companies are charting divergent courses for their futures. Some continue to bet on their ability to generate returns from the O&G value chain. They are focusing on growing margins and lowering carbon intensity. Others are supplementing their capabilities with low-carbon energy solutions or exiting hydrocarbons altogether. This blog focuses on the path forward for the energy majors in Europe who are betting big on diversification.

Read More

Spotlight

Avanir Pharmaceuticals

A company with a cause. People with a passion. Together, they make a world of difference. Every day at Avanir Pharmaceuticals, Inc. we focus on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. That focus, along with the deep-seated passion of our people, is fueling the development of innovative medical solutions. It’s a personal thing for us. If you’ve ever known someone suffering from a CNS disorder, you probably understand. Millions of people struggle daily with these complex and difficult conditions and yet, there are no perfect solutions. Enter Avanir where our vision is to become the leading pharmaceutical company in the CNS space because that, in turn, will enable us to follow our passion of helping CNS patients every day. And we think that’s a great thing to do.

Events